Spyre Therapeutics, Inc. Income Statement

Income Statement Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 6.08M4.63M5.21M3.90M18.74M2.33M0.89M
Gross Profit 6.08M4.63M5.21M3.90M18.74M2.33M0.89M
Operating items
Research & Development 6.83M11.45M18.14M22.82M36.72M64.60M59.64M57.07M58.58M89.50M162.79M
Selling, General & Administrative 2.07M5.95M8.39M10.07M12.63M15.73M21.84M27.32M28.53M39.95M45.78M
Other Operating Expenses 16.45M
Operating Expenses 8.90M17.40M26.53M32.88M49.35M80.33M81.48M84.39M87.11M243.19M208.57M
Operating Income -8.90M-11.31M-21.91M-27.68M-45.46M-80.33M-81.48M-65.65M-84.78M-242.30M-208.57M
EBIT -8.90M-11.31M-21.91M-27.68M-45.46M-80.33M-81.48M-65.65M-84.78M-242.30M-208.57M
Non-operating items
Non Operating Investment Income -83.53M-20.43M
Interest & Investment Income 0.00M0.02M0.24M0.48M1.17M2.14M0.59M0.11M0.84M6.15M21.31M
Other Non Operating Income -1.44M-0.00M-0.04M-0.04M-0.06M-0.06M-0.01M-0.12M-0.01M-19.13M-20.71M
Non Operating Income -1.44M0.02M0.21M0.44M1.11M2.08M0.59M-0.12M0.83M-96.51M-20.71M
Net income details
EBT -8.90M-11.29M-21.66M-27.19M-44.29M-78.25M-80.89M-65.66M-83.95M-338.82M-207.97M
Tax Provisions 0.14M-0.14M-0.03M0.05M
Profit After Tax -10.35M-11.29M-21.70M-27.24M-44.35M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Income from Continuing Operations -8.90M-11.29M-21.66M-27.19M-44.29M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Consolidated Net Income -8.90M-11.29M-21.66M-27.19M-44.29M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Income towards Parent Company -8.90M-11.29M-21.66M-27.19M-44.29M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Preferred Dividend Payments 0.23M
Net Income towards Common Stockholders -10.35M-11.52M-21.70M-27.24M-44.29M-78.25M-80.89M-65.80M-83.81M-338.79M-208.02M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.46M0.54M0.67M0.96M1.16M1.92M1.97M2.46M4.05M51.43M
Shares Outstanding (Diluted Average) 53.37M2.63M3.37M6.90M47.03M
EBITDA -8.90M-11.31M-21.91M-27.68M-45.46M-80.33M-81.48M-65.65M-84.78M-242.30M-208.57M
Shares Outstanding 0.35M0.76M13.43M16.67M24.14M29.08M47.96M1.97M2.61M36.06M
Tax Rate 0.00M0.00M